Peer Review Panel Comments on the AR Binding Assay

First Page		Document Content
Date: 2008-03-24 10:32:06 Pharmacology Laboratory techniques Chemical bonding Assay Biochemistry Titration Receptor antagonist Androgen receptor Ligand Chemistry Biology Cell biology		Peer Review Panel Comments on the AR Binding Assay Add to Reading List Source URL: www.epa.gov Download Document from Source Website File Size: 46,78 KB Share Document on Facebook

	Abstract # 3991 Novel small molecule inhibitor of p300/CBP down-regulates androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond CellCentric DocID: 1vi4a - View Document
	Proceedings of the British Pharmacological Society at http://www.pA2online.org/abstracts/Vol7Issue4abst086P.pdf Using the fluorescent antagonist, XAC-X-BY630 to quantify antagonist-adenosine A3 receptor complexes in mem DocID: 1qBQB - View Document
	SpringHAUPTMAN-WOODWARD INSTITUTE An Independent Non-Profit Biomedical Research Institute PROSTATE CANCER is the most frequently diagnosed male cancer. DocID: 1pTiN - View Document
	Application examples for the Mammalian-2-Hybrid system M2H - Liver X Receptor alpha (LXRa) plus NCoA3 and Liver X Receptor alpha plus NCoR with control agonist T0901317 M2H - Androgen Receptor (AR) plus NCoA3 with contr DocID: 1nxYE - View Document
	Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancer Xiaochuan Shan1 , Gwenn Danet-Desnoyers1 , Juan Jos´e Fung2 , Alan H. Kosaka2 , Fraser Tan3 , Nicole Perfito3 , Joelle DocID: 1lWYj - View Document